A few studies have illustrated aberrant regulation of ADAMTS-5 in vascular diseases, including atherosclerosis [23, 24], cerebral cavernous malformation [25], calcific aortic valve disease (CAVD) [26], and aortic dilatation [27]. This evidence concerns the gene ADAMTS5 and congenital bilateral aplasia of vas deferens from CFTR mutation.